课题基金 / 基金详情

项目摘要

项目成果

Jose G Trevino的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要/摘要-行政核心 行政核心(AC)将为弗吉尼亚联邦大学提供组织基础设施- 梅西癌症中心差异相关患者衍生异种移植物开发和试验中心(VCU/MCC- D-PDTC)。通过我们的集体努力,VCU/MCC-D-PDTC(以下简称为“健康公平联盟”) - Living PDX计划(U4 HELPP)将获得和开发患者来源的异种移植物(PDX)和类器官 (PDO)主要来自胰腺癌,乳腺癌, 泌尿生殖系统(GU)、妇科(GYN)、肺以及原发性和晚期胃肠道恶性肿瘤。的 U4 HELPP利用VCU梅西癌症中心和VCU健康的领导和基础设施, 是一个安全网医疗保健系统,为英联邦代表性不足的少数民族癌症患者提供服务。 弗吉尼亚我们的团队也将利用我们互补的专业知识、研究兴趣和技术 作为我们PDX/PDO专业知识的集体广度,以促进最大的项目协同作用和生产力。交流 我将与一个咨询委员会互动,该委员会包括临床肿瘤学、PDX 发展、差异研究、癌症预防和患者倡导者。通过与NCI的互动, 顾问委员会会就项目提供指导和监督,以确保整项研究能及时取得进展。 总体而言,AC将提供强有力的组织监督,以开发与安全性相关的PDX(D-PDX)模型 这将在我们支持U4 HELPP研究项目和核心的机构内使用,与内部共享 和PDX Net合作者,并提供给NCI患者衍生模型库(PDMR)。
英文摘要
PROJECT SUMMARY / ABSTRACT – ADMINISTRATIVE CORE The Administrative Core (AC) will provide organizational infrastructure for Virginia Commonwealth University - Massey Cancer Center Disparity-relevant Patient-Derived Xenograft Development and Trial Center (VCU/MCC- D-PDTC). Through our collective efforts the VCU/MCC-D-PDTC known hereafter as United for Health Equity - Living PDX Program (U4HELPP) will obtain and develop patient-derived xenografts (PDX) and organoids (PDO) primarily from underrepresented minority tumor samples from cancers of the pancreas, breast, genitourinary (GU), gynecologic (GYN), lung and primary and advanced gastrointestinal tract malignancies. The U4HELPP leverages the leadership and infrastructure of the VCU Massey Cancer Center and VCU Health which is a safety net health care system serving underrepresented minority cancer patients in the Commonwealth of Virginia. Our team will capitalize on our complementary expertise, research interests, and technologies, as well as our collective breadth of PDX/PDO expertise, to promote maximum project synergy and productivity. The AC will interact with an Advisory Board that includes strong leaders in the fields of clinical oncology, PDX development, disparities research, cancer prevention, and patient advocates. Through interactions with the NCI, the AC will provide direction and oversight of the project to ensure timely progress on the entirety of the studies. Overall, the AC will provide strong organizational oversight to develop disparity-relevant PDX (D-PDX) models that will be used within our institution supporting U4HELPP Research Projects and Cores, shared with internal and PDX Net collaborators, and provided to the NCI Patient-Derived Models Repository (PDMR).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
  • 批准号:
    9813626
  • 项目类别:
  • 资助金额:
    $52.57万
  • 财政年份:
    2019
  • 负责人:
    Jose G Trevino
  • 依托单位:
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
  • 批准号:
    10005295
  • 项目类别:
  • 资助金额:
    $52.57万
  • 财政年份:
    2019
  • 负责人:
    Jose G Trevino
  • 依托单位:
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models
  • 批准号:
    10006213
  • 项目类别:
  • 资助金额:
    $10.37万
  • 财政年份:
    2018
  • 负责人:
    Jose G Trevino
  • 依托单位:
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models
  • 批准号:
    10006222
  • 项目类别:
  • 资助金额:
    $2.18万
  • 财政年份:
    --
  • 负责人:
    Jose G Trevino
  • 依托单位:
海外基金